Global Infection Control Market - Global Forecast to 2027

Share

Global Infection Control Market - Global Forecast to 2027


 Category : Healthcare

 Published: Nov-2021
 Author: SPER Analyst


Global Infection Control Market is projected to be worth ~$ 54.82 Billion by 2027

The global infection control market is expected to grow at a CAGR of ~3.3% from 2021 to reach USD 54.82 billion by 2027. The growth is primarily attributed to prevalence of infectious diseases, rising geriatric population, rising focus on sterilization, technological advancements, expansion of pharmaceutical companies and medical devices in emerging economies, increasing number of surgical procedures and rising outsourcing of sterilization services. However, safety aspect of reprocessed instruments can hinder the growth of this market. COVID-19 has offered significant growth opportunity to the market players.

Browse report overview on "Global Infection Control Market" at: https://www.sperresearch.com/report-store/Infection-Control.aspx

The global infection control market study provides market data for-by product & services (sterilization products & services, cleaning & disinfection products, protective barriers, endoscope reprocessing products, other infection control products), by end user (hospitals & clinics, medical device companies, pharmaceutical companies, life science industry, food industry, other end users). The study also evaluates industry competitors and analyses the market at a regional and country level.

Protective barrier segment dominated the infection control market in 2020 and will show similar trend in the forecast period. The largest share of this market is mainly due to significant rise adoption of medical non-woven such as masks, gowns, face masks due to COVID-19 pandemic.  

By end user, hospitals & clinics segment accounted for the largest share of infection control market in 2020. The large share of this segment can be attributed to supportive government initiatives, prevalence of infectious diseases, rising number of hospitals & clinics and growing geriatric population. However, increasing number of COVID-19 has also increased the adoption of sterilization and disinfectants in the hospitals.

Don’t miss out on business opportunities in the "Global Infection Control Market". Request customized report as per your need and gain crucial industry insights that will help your business grow at: https://www.sperresearch.com/report-store/Infection-Control.aspx?custom=1

This research report analyses major geographies and provides a comprehensive analysis of North America (US, Canada), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia-Pacific (China, India, Japan, and RoAPAC), Rest of the world (Latin America, and Middle East & Africa). North America accounted for largest share of Infection control market. The largest share of this regional segment can be attributed to rising geriatric population, prevalence of chronic diseases, favorable government initiatives, stringent regulation on sterilization, increasing focus on healthy lifestyle and growing demand for adoption of sterilization products. APAC is expected to grow at highest CAGR during the forecast period. High growth of this geographic segment is mainly attributed to outsourcing of sterilization services in emerging economies such as India, China, rising awareness towards spread of infections and measures of prevention of infections.

The major players operating in the global infection control market are 
  • Getinge AB (Sweden)
  • STERIS plc. (US)
  • Advanced Sterilization Products (US)
  • 3M Company (US)
  • Belimed AG (Switzerland)
  • Cantel Medical Corporation (US)
  • MMM Group (Germany)
  • MATACHANA GROUP (Spain)
  • Sotera Health LLC (US)
  • Ecolab, Inc. (US)
  • Metrex Research Corporation (US)
  • Reckitt Benckiser Group Plc. (UK)
  • Miele Group (Germany)
  • Melag (Germany)
  • Pal International (UK)

Join Our SPER Panel

Our Global Clients

Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
SPER-Astellas Pharma
SPER-Citi Bank
SPER-Microsoft
SPER-EY
SPER-McKinsey
SPER-Bain
SPER-Max-Healthcare
SPER-DHL
SPER-SIEMENS
SPER-IQVIA
SPER-Pfizer
SPER-LOREAL
SPER-Kankar IMRB
SPER-ITA
SPER-PWC
SPER-Sanofi
SPER-p&g
SPER-Johnson & Johnson
SPER-IPSOS
SPER-Heineken

SPER

Market Research

We are the leading, full-service global market research and consulting company.

Certificates
iso-1 iso-1 iso-1 ESOMAR
Secure Payments
SPER Payment Options
Contact HR

 [email protected]

 +91-742-898-5650